Saturday, February 20, 2010

7:00 am      Continental breakfast and registration

8:00     Welcome - Overview and Update from San Antonio Breast Cancer Symposium  

Edith A. Perez, M.D.     

Predictive Markers

8:15     What is new in pathological issues, predictive markers and circulating tumor cells? Beiyun Chen, MD PhD

 

8:35        What is new in breast cancer surgery and management of sentinel node findings    Sarah A. McLaughlin, M.D.

 

9:05        Pathology issues in sentinel node findings – Ann E. McCullough, M.D.

Endocrine and Anti Her-2 Therapies

9:15        Endocrine therapy for young women with breast cancer                    Kimberly L. Blackwell, M.D.

9:45        Management of HER2 positive metastatic breast cancer: standard and new approaches          Sandra Swain, M.D.

10:15      Break

10:30      Adjuvant and localized advanced Her2+ breast cancer                              Edith A. Perez, M.D.

11:00      Panel Discussion – Moderator:  Edith A. Perez, MD  (Chen, McLaughlin, Blackwell, Swain, Hartmann)

Novel Treatments

11:30      Bisphosphonates and other bone modulating agents in the adjuvant setting: for whom should they be recommended?                  Julie Gralow, MD

12:00pm   Novel Anti-cancer Agents for “Triple Negative” Breast Cancer  Debu Tripathy, M.D.

12:30   Panel Discussion – Moderator:  Edith A. Perez, MD   (Gralow, Moreno-Aspitia, Patel Tripathy)

             1:00        Lunch

Risk Factors and Prevention

1:20     What is new in epidemiology, risk factors and prevention of breast cancer?     Judy E. Garber, MD MPH            

1:50        Molecular breast imaging    Deborah J. Rhodes, MD

2:20        Exercise and Obesity:  Impact upon breast cancer risk and outcomes                            Kathryn Schmitz, PhD  MPH

2:50        Panel Discussion – Moderator:  Lynn C. Hartmann, MD     (Perez, Garber, Rhodes, Schmitz)